by msyoung2012 on 11/8/22, 3:46 PM with 182 comments
by martey on 11/8/22, 4:20 PM
by cmrivers on 11/8/22, 4:55 PM
by exhilaration on 11/8/22, 4:24 PM
by photochemsyn on 11/8/22, 5:26 PM
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495366/
The virus apparently just wrecks the immune system right off the bat, allowing it to rampage throughout the body unchecked. Hence immune-system-support therapies are being worked on:
> "EBOV is able to evade innate and adaptive (both humoral and cellular) responses by encoding for multiple viral proteins that inhibit both type-I IFNs synthesis and response, by masking viral epitopes by glycosylation processes, by deregulating inflammatory response, by preventing DC maturation, thus resulting in a catastrophic failure of innate and adaptive immunity. Thus host factors have a key role for viral replication and release, and may represent good targets for therapeutic strategies."
The for-profit pharmaceutical system isn't that interested in this, as not many people or governments in Africa have the funds to pay for research, production, and what is it now, a guaranteed 15%+ profit margin?
by VBprogrammer on 11/8/22, 4:25 PM
by msyoung2012 on 11/8/22, 3:46 PM
by 6stringmerc on 11/8/22, 4:40 PM
by Closi on 11/8/22, 7:58 PM
https://www.telegraph.co.uk/content/dam/global-health/2022/1...
1) The forecast appears to be "200 new cases per month" (i.e. Month 1 is 200 cases, Month 3 is 600 cases (3200) and Month 4 is 1200 cases (6200)). This is far too simplistic, and should probably follow an exponential/logistic curve if r>1.
2) The graph has simple stats failures like plotting a line between a bar chart.
Doesn't give me too much hope for the other 15 slides...
(The above isn't to say that it isn't a scary situation - clearly this is an awful situation which needs a huge amount of support. But the apparent quality of analysis does worry me that decision makers might not be working on great information)
by max_ on 11/8/22, 6:52 PM
by doodlebugging on 11/8/22, 7:41 PM
There is a place that accepts products that are obsolete and reusable and they have a section dedicated to PPE since a lot of outfits obsoleted their PPE inventories once Covid was better controlled.
They also have a shit-ton or more of other things that can be repurposed from their original tasks.
Repurposed Materials - Sanitary stuff [0]
by alexk307 on 11/8/22, 6:07 PM
by nlitsme on 11/8/22, 6:10 PM
Their graph has two lines: (month 0 == december)
- totalcases = 180*month+300
- totaldeaths = 83*month+84
Recent experience with covid shows that usually epidemics initially grow exponentially.
by tibbydudeza on 11/8/22, 5:25 PM
by ccbccccbbcccbb on 11/8/22, 8:46 PM